Use of dominant negative mutants of the
β
P Scaglioni; M Melegari; M Takahashi; J R Chowdhury; J Wands
π
Article
π
1996
π
John Wiley and Sons
π
English
β 355 KB
needed to reduce the risk of developing chronic liver disease Chronic hepatitis B virus (HBV) infection is a major and HCC in chronic HBV carriers. Current established thercause of acute and chronic liver diseases. We have reapy involves treatment with interferon alfa but results in cently described